triptorelin
UkraineDrugs containing this active substance
-
The drug is used to prevent the premature rise in luteinizing hormone (LH) levels in women undergoing controlled ovarian stimulation as part of assisted reproductive technologies.
Form: solution for injection
Active substance Dosage triptorelin 0.1 mg/ml ATC: L02AE04
Manufacturer: Ferring GmbH (responsible for manufacturing of finished product, primary packaging, quality control and batch release)
-
The drug is used to treat hormone-dependent prostate cancer in men, uterine fibroids and endometriosis in women, as well as to prevent premature ovulation when using assisted reproductive technologies. In children, the drug is prescribed for the treatment of confirmed precocious puberty.
Form: powder for injection suspension
Active substance Dosage triptorelin 3.75 mg ATC: L02AE04
Manufacturer: Ferring GmbH (responsible for manufacturing of finished product, primary packaging, quality control and batch release)
-
The drug is used for the treatment of prostate cancer (localized or metastatic), endometriosis, uterine fibroids, breast cancer in premenopausal women, as well as for the treatment of central precocious puberty in children and female infertility.
Form: powder and solvent for suspension for injection, prolonged release
Active substance Dosage triptorelin 3.75 mg ATC: L02AE04
-
The drug is used to treat female infertility, specifically for ovulation induction for the purpose of in vitro fertilization (IVF) and subsequent embryo transfer.
Form: powder and solvent for injection solution
Active substance Dosage triptorelin 0.1 mg ATC: L02AE04
Manufacturer: IPSEN PHARMA BIOTECH (powder - manufacturing, testing, packaging, batch release; secondary packaging, batch release)
-
The drug is used for the treatment of advanced or metastatic prostate cancer, endometriosis (in women), as well as for the treatment of central precocious puberty in children.
Form: powder and solvent for suspension for injection, prolonged release
Active substance Dosage triptorelin 11.25 mg or 15 mg ATC: L02AE04
-
The drug is used for the treatment of advanced or metastatic hormone-sensitive prostate cancer, as well as in combination with radiotherapy for high-risk localized cancer. It is also prescribed to children (girls up to 8 years of age and boys up to 10 years of age) for central precocious puberty.
Form: powder and solvent for suspension for injection with prolonged release
Active substance Dosage triptorelin 22.5 mg ATC: L02AE04
Manufacturer: Debiopharm Research and Manufacturing S.A. (manufacturing, primary packaging, quality control and stability testing: powder)